IL-2 regulates expression of C-MAF in human CD4 T cells

Journal of Immunology

Volumn 187, Issue 7, 2011, Pages 3721-3729

  Rani, Aradhana ^a   Afzali, Behdad ^a   Kelly, Audrey ^a   Tewolde Berhan, Lemlem ^a   Hackett, Mark ^a   Kanhere, Aditi S ^b   Pedroza Pacheco, Isabela ^b   Bowen, Holly ^a   Jurcevic, Stipo ^a   Jenner, Richard G ^b   Cousins, David J ^a   Ragheb, Jack A ^c   Lavender, Paul ^a   John, Susan ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACLIZUMAB; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 6; JANUS KINASE 3 INHIBITOR; MESSENGER RNA; STAT5 PROTEIN; T LYMPHOCYTE RECEPTOR;

ARTICLE; BINDING SITE; C MAF GENE; CD4+ T LYMPHOCYTE; CHROMATIN; CONTROLLED STUDY; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IL4 GENE; LYMPHOCYTE DIFFERENTIATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION; TH2 CELL;

BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL SEPARATION; CHROMATIN IMMUNOPRECIPITATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-2; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-MAF; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; TH2 CELLS;

EID: 80053508778     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002354     Document Type: Article

References (44)

1. Levy, D. E., and J. E. Darnell, Jr. 2002. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3: 651-662. (Pubitemid 34987786)
2. Lin, J. X., and W. J. Leonard. 2000. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines. Oncogene 19: 2566-2576.
3. Moriggl, R., V. Sexl, R. Piekorz, D. Topham, and J. N. Ihle. 1999. Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells. Immunity 11: 225-230. (Pubitemid 29428815)
4. Moriggl, R., D. J. Topham, S. Teglund, V. Sexl, C. McKay, D. Wang, A. Hoffmeyer, J. Van Deursen, M. Y. Sangster, K. D. Bunting, et al. 1999. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 10: 249-259. (Pubitemid 29115630)
5. Hoelbl, A., B. Kovacic, M. A. Kerenyi, O. Simma, W. Warsch, Y. Cui, H. Beug, L. Hennighausen, R. Moriggl, and V. Sexl. 2006. Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation. Blood 107: 4898-4906. (Pubitemid 43882643)
6. Kagami, S., H. Nakajima, A. Suto, K. Hirose, K. Suzuki, S. Morita, I. Kato, Y. Saito, T. Kitamura, and I. Iwamoto. 2001. Stat5a regulates T helper cell differentiation by several distinct mechanisms. Blood 97: 2358-2365. (Pubitemid 32291482)
7. Burchill, M. A., J. Yang, C. Vogtenhuber, B. R. Blazar, and M. A. Farrar. 2007. IL-2 receptor b-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J. Immunol. 178: 280-290. (Pubitemid 46033611)
8. Birney, E., J. A. Stamatoyannopoulos, A. Dutta, R. Guigó, T. R. Gingeras, E. H. Margulies, Z. Weng, M. Snyder, E. T. Dermitzakis, R. E. Thurman, et al ENCODE Project Consortium; NISC Comparative Sequencing Program; Baylor College of Medicine Human Genome Sequencing Center; Washington University Genome Sequencing Center; Broad Institute; Children's Hospital Oakland Research Institute. 2007. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447: 799-816.
9. Northrup, D. L., and K. Zhao. 2011. Application of ChIP-Seq and related techniques to the study of immune function. Immunity 34: 830-842.
10. Barski, A., S. Cuddapah, K. Cui, T. Y. Roh, D. E. Schones, Z. Wang, G. Wei, I. Chepelev, and K. Zhao. 2007. High-resolution profiling of histone methylations in the human genome. Cell 129: 823-837. (Pubitemid 46802390)
11. Kim, T. K., M. Hemberg, J. M. Gray, A. M. Costa, D. M. Bear, J. Wu, D. A. Harmin, M. Laptewicz, K. Barbara-Haley, S. Kuersten, et al. 2010. Widespread transcription at neuronal activity-regulated enhancers. Nature 465: 182-187.
12. Jin, C., C. Zang, G. Wei, K. Cui, W. Peng, K. Zhao, and G. Felsenfeld. 2009. H3.3/H2A.Z double variant-containing nucleosomes mark "nucleosome- free regions" of active promoters and other regulatory regions. Nat. Genet. 41: 941-945.
13. Adamson, A. S., K. Collins, A. Laurence, and J. J. O'Shea. 2009. The current STATus of lymphocyte signaling: new roles for old players. Curr. Opin. Immunol. 21: 161-166.
14. Ben-Sasson, S. Z., G. Le Gros, D. H. Conrad, F. D. Finkelman, and W. E. Paul. 1990. IL-4 production by T cells from naive donors: IL-2 is required for IL-4 production. J. Immunol. 145: 1127-1136. (Pubitemid 20258714)
15. McDyer, J. F., Z. Li, S. John, X. Yu, C. Y. Wu, and J. A. Ragheb. 2002. IL-2 receptor blockade inhibits late, but not early, IFN-γ and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-γ production. J. Immunol. 169: 2736-2746. (Pubitemid 34921023)
16. Zhu, J., J. Cote-Sierra, L. Guo, and W. E. Paul. 2003. Stat5 activation plays a critical role in Th2 differentiation. Immunity 19: 739-748. (Pubitemid 37490798)
17. Liao, W., D. E. Schones, J. Oh, Y. Cui, K. Cui, T. Y. Roh, K. Zhao, and W. J. Leonard. 2008. Priming for T helper type 2 differentiation by interleukin 2- mediated induction of interleukin 4 receptor α-chain expression. Nat. Immunol. 9: 1288-1296.
18. Cote-Sierra, J., G. Foucras, L. Guo, L. Chiodetti, H. A. Young, J. Hu-Li, J. Zhu, and W. E. Paul. 2004. Interleukin 2 plays a central role in Th2 differentiation. Proc. Natl. Acad. Sci. USA 101: 3880-3885. (Pubitemid 38381071)
19. Ho, I. C., M. R. Hodge, J. W. Rooney, and L. H. Glimcher. 1996. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85: 973-983.
20. Ho, I. C., D. Lo, and L. H. Glimcher. 1998. c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms. J. Exp. Med. 188: 1859-1866. (Pubitemid 28536773)
21. Bauquet, A. T., H. Jin, A. M. Paterson, M. Mitsdoerffer, I. C. Ho, A. H. Sharpe, and V. K. Kuchroo. 2009. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells. Nat. Immunol. 10: 167-175.
22. Saraiva, M., J. R. Christensen, M. Veldhoen, T. L. Murphy, K. M. Murphy, and A. O'Garra. 2009. Interleukin-10 production by Th1 cells requires interleukin- 12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 31: 209-219.
23. Xu, J., Y. Yang, G. Qiu, G. Lal, Z. Wu, D. E. Levy, J. C. Ochando, J. S. Bromberg, and Y. Ding. 2009. c-Maf regulates IL-10 expression during Th17 polarization. J. Immunol. 182: 6226-6236.
24. Yang, Y., J. Ochando, A. Yopp, J. S. Bromberg, and Y. Ding. 2005. IL-6 plays a unique role in initiating c-Maf expression during early stage of CD4 T cell activation. J. Immunol. 174: 2720-2729. (Pubitemid 40279687)
25. Nelson, E. A., S. R. Walker, J. V. Alvarez, and D. A. Frank. 2004. Isolation of unique STAT5 targets by chromatin immunoprecipitation-based gene identification. J. Biol. Chem. 279: 54724-54730. (Pubitemid 40053217)
26. Cousins, D. J., T. H. Lee, and D. Z. Staynov. 2002. Cytokine coexpression during human Th1/Th2 cell differentiation: direct evidence for coordinated expression of Th2 cytokines. J. Immunol. 169: 2498-2506. (Pubitemid 34920994)
27. Lin, J. X., J. Mietz, W. S. Modi, S. John, and W. J. Leonard. 1996. Cloning of human Stat5B: reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells. J. Biol. Chem. 271: 10738-10744. (Pubitemid 26145810)
28. John, S., U. Vinkemeier, E. Soldaini, J. E. Darnell, Jr., and W. J. Leonard. 1999. The significance of tetramerization in promoter recruitment by Stat5. Mol. Cell. Biol. 19: 1910-1918. (Pubitemid 29098249)
29. Xi, H., H. P. Shulha, J. M. Lin, T. R. Vales, Y. Fu, D. M. Bodine, R. D. McKay, J. G. Chenoweth, P. J. Tesar, T. S. Furey, et al. 2007. Identification and characterization of cell type-specific and ubiquitous chromatin regulatory structures in the human genome. PLoS Genet. 3: e136.
30. Boyle, A. P., S. Davis, H. P. Shulha, P. Meltzer, E. H. Margulies, Z. Weng, T. S. Furey, and G. E. Crawford. 2008. High-resolution mapping and characterization of open chromatin across the genome. Cell 132: 311-322. (Pubitemid 351172431)
31. Soldaini, E., S. John, S. Moro, J. Bollenbacher, U. Schindler, and W. J. Leonard. 2000. DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites. Mol. Cell. Biol. 20: 389-401. (Pubitemid 30002580)
32. Ghoreschi, K., A. Laurence, and J. J. O'Shea. 2009. Selectivity and therapeutic inhibition of kinases: to be or not to be? Nat. Immunol. 10: 356-360.
33. Malek, T. R., A. Yu, L. Zhu, T. Matsutani, D. Adeegbe, and A. L. Bayer. 2008. IL-2 family of cytokines in T regulatory cell development and homeostasis. J. rClin. Immunol. 28: 635-639.
34. Durant, L., W. T. Watford, H. L. Ramos, A. Laurence, G. Vahedi, L. Wei, H. Takahashi, H. W. Sun, Y. Kanno, F. Powrie, and J. J. O'Shea. 2010. Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity 32: 605-615.
35. Dennehy, K. M., F. Elias, S. Y. Na, K. D. Fischer, T. Hünig, and F. Lühder. 2007. Mitogenic CD28 signals require the exchange factor Vav1 to enhance TCR signaling at the SLP-76-Vav-Itk signalosome. J. Immunol. 178: 1363-1371. (Pubitemid 46154606)
36. Tanaka, Y., T. So, S. Lebedeva, M. Croft, and A. Altman. 2005. Impaired IL-4 and c-Maf expression and enhanced Th1-cell development in Vav1-deficient mice. Blood 106: 1286-1295. (Pubitemid 41129592)
37. Stritesky, G. L., R. Muthukrishnan, S. Sehra, R. Goswami, D. Pham, J. Travers, E. T. Nguyen, D. E. Levy, and M. H. Kaplan. 2011. The transcription factor STAT3 is required for T helper 2 cell development. Immunity 34: 39-49.
38. Nurieva, R. I., J. Duong, H. Kishikawa, U. Dianzani, J. M. Rojo, I. Ho, R. A. Flavell, and C. Dong. 2003. Transcriptional regulation of Th2 differentiation by inducible costimulator. Immunity 18: 801-811. (Pubitemid 36776429)
39. + T cells during Th cell development. J. Immunol. 171: 783-794.
40. Mesturini, R., S. Nicola, A. Chiocchetti, I. S. Bernardone, L. Castelli, T. Bensi, M. Ferretti, C. Comi, C. Dong, J. M. Rojo, et al. 2006. ICOS cooperates with CD28, IL-2, and IFN-γ and modulates activation of human naive CD4+ T cells. Eur. J. Immunol. 36: 2601-2612. (Pubitemid 44608444)
41. + T cells to generate a Th2-inducing cytokine environment. J. Exp. Med. 202: 793-804.
42. Hwang, E. S., I. A. White, and I. C. Ho. 2002. An IL-4-independent and CD25- mediated function of c-maf in promoting the production of Th2 cytokines. Proc. Natl. Acad. Sci. USA 99: 13026-13030.
43. Apetoh, L., F. J. Quintana, C. Pot, N. Joller, S. Xiao, D. Kumar, E. J. Burns, D. H. Sherr, H. L. Weiner, and V. K. Kuchroo. 2010. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol. 11: 854-861.
44. Busse, W. W., E. Israel, H. S. Nelson, J. W. Baker, B. L. Charous, D. Y. Young, V. Vexler, and R. S. Shames; Daclizumab Asthma Study Group. 2008. Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial. Am. J. Respir. Crit. Care Med. 178: 1002-1008.